# Does Ozempic Cause Hair Loss? What 1,091,743 Records Show | This GLP

Pooled across 17 studies, GLP-1 use raised the odds of non-scarring hair loss to 1.40. Telogen effluvium rose to 1.76; autoimmune alopecia areata did not rise at all.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/research/does-ozempic-cause-hair-loss
Updated: 2026-09-17
Published: 2026-09-17

[← Research](https://thisglp.com/research)

Safety

# Does Ozempic Cause Hair Loss? What 1,091,743 Records Show

Pooled across 1,091,743 exposures, the odds are raised about 40%. The kind of hair loss that goes up points at the weight you lost, not the drug.

[This GLP Editorial Team](https://thisglp.com/about)September 20267 min read

Odds of each kind of hair loss, pooled · 1.0 · any non-scarring · telogen effluvium · androgenetic · alopecia areata · The autoimmune one is the one that does not move.

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).

## Key takeaways

-   Yes, modestly. Pooled across 17 studies and 1,091,743 patient-exposures, the odds of non-scarring hair loss were 1.40 (95% CI 1.33 to 1.48).
-   The subtype matters: telogen effluvium — the shedding that follows rapid weight loss — was raised at 1.76, while autoimmune alopecia areata was not raised at all (1.08, 95% CI 0.87 to 1.34).
-   In a separate matched cohort, GLP-1 users who experienced hair loss had a LOWER follow-up BMI than those who did not.
-   Together those point at fast weight loss as the driver rather than anything specific to the molecule — though no trial has tested that directly.

The short answer is yes, a little, and probably not for the reason people assume. A 2026 systematic review and meta-analysis pooled 17 studies covering 1,091,743 patient-exposures and found the odds of any non-scarring alopecia raised at 1.40, with a confidence interval from 1.33 to 1.48 and no measurable heterogeneity between the cohort studies [\[1\]](https://thisglp.com/research/does-ozempic-cause-hair-loss#ref-1).

That is a real signal and a small one. It is also an average taken across very different conditions that happen to share the word “alopecia”, and splitting them apart is where the useful answer turns out to live.

## Which kind of hair loss actually goes up

Pooled odds ratios by alopecia subtype, 17 studies.
| Type of hair loss | Pooled odds at 12 months | Raised? |
| --- | --- | --- |
| Any non-scarring alopecia | 1.40 (95% CI 1.33–1.48) | Yes |
| Telogen effluvium | 1.76 (95% CI 1.34–2.32) | Yes |
| Androgenetic alopecia | 1.64 (95% CI 1.35–1.99) | Yes |
| Alopecia areata | 1.08 (95% CI 0.87–1.34) | No — interval crosses 1 |

Pooled odds ratios by alopecia subtype, 17 studies. Systematic review and meta-analysis, 1,091,743 patient-exposures

Telogen effluvium is diffuse shedding that begins two to four months after a physiological stress, which is the detail that makes the timing recognizable to anyone it has happened to. Rapid weight loss is one of the classic triggers, alongside illness, surgery and childbirth — the same stress response behind the lean-mass changes in [what is lost and what returns](https://thisglp.com/research/do-you-lose-muscle-on-a-glp1). Alopecia areata, by contrast, is autoimmune and patchy, and it has nothing to do with how much weight somebody has lost or how quickly they lost it. The first of those is raised here and the second is not, and that split is the closest thing this literature has to an explanation.

Two different studies used the same negative control, and both came back clean

Alopecia areata was not merely unmeasured — a propensity-matched cohort study built on US health records deliberately used it as a _negative control_ outcome, on the reasoning that a drug causing weight-related shedding should not also cause an autoimmune patchy condition [\[2\]](https://thisglp.com/research/does-ozempic-cause-hair-loss#ref-2). It came back null there too. When a study names a control in advance and the control behaves, the rest of its findings get more credible — the practice this site praised in [the cohort that tested its own bias](https://thisglp.com/research/do-glp1-drugs-prevent-heart-attacks-and-strokes).

## The clue that points at the weight, not the drug

The same matched cohort reports one observation that does more work than any odds ratio in it: among GLP-1 users, the people who developed hair loss had a _lower_ follow-up BMI than the people who did not. The ones who lost more hair were the ones who lost more weight.

That is consistent with telogen effluvium being the mechanism, because on that reading the shedding tracks the speed and the size of the weight change rather than anything about the molecule itself. It is an association found inside an observational cohort rather than a randomized comparison, which makes it a strong hint about the mechanism rather than proof of it. Nobody has run a trial that holds weight loss constant and varies the drug, which is the experiment that would settle it. It is the same reasoning problem this site worked through in [separating a drug effect from a weight effect](https://thisglp.com/research/liver-repair-that-was-not-the-weight).

## Why you will still find sources saying the evidence conflicts

Because until very recently it genuinely did, and the pages saying so were describing the evidence accurately at the time they were written. A 2025 systematic review found only five primary studies covering 2,905 adults, and they disagreed with each other — some reported hair loss as an adverse event, others reported improvement and regrowth [\[3\]](https://thisglp.com/research/does-ozempic-cause-hair-loss#ref-3). That was an honest description of a thin evidence base. The 2026 meta-analysis is roughly 375 times larger by exposures, which is what changed.

Pages written against that older review are not wrong about what it said, and it would be unfair to read them as careless. They are just describing the state of the field before the larger synthesis landed.

## Does it matter which drug you are on?

On current evidence, not much. The matched cohort found higher odds of non-scarring alopecia with both semaglutide and tirzepatide compared with other GLP-1 drugs, and higher odds of telogen effluvium with tirzepatide across every follow-up window it examined [\[2\]](https://thisglp.com/research/does-ozempic-cause-hair-loss#ref-2). The published summary reports those as directions rather than as odds ratios, so this site will not attach numbers to them.

Since semaglutide and tirzepatide are also the two that take off the most weight — the gap measured in [the real-world comparison of the two](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) — a difference between molecules and a difference in weight lost cannot be separated here either.

What this article is not

This is a summary of what has been measured across populations. It is not a diagnosis, and nothing here is a reason to stop or change a prescription on your own. Diffuse shedding that starts months after rapid weight loss, patchy round bald spots, and hair thinning at the crown are three different things with three different workups, and telling them apart is a clinician’s job.

## Frequently asked

Does Ozempic cause hair loss?

Pooled across 17 studies and over a million patient-exposures, GLP-1 use raised the odds of non-scarring hair loss to 1.40 (95% CI 1.33 to 1.48). That is a real but modest increase.

What kind of hair loss is it?

Mostly telogen effluvium — diffuse shedding that follows a physiological stress such as rapid weight loss — at pooled odds of 1.76. Autoimmune alopecia areata was not raised, at 1.08 with an interval crossing 1.

Is it the drug or the weight loss?

The evidence leans toward the weight loss. Users who developed hair loss had a lower follow-up BMI than those who did not, and the subtype raised is the one classically triggered by rapid weight change. No trial has separated the two directly.

Does tirzepatide cause more hair loss than semaglutide?

A matched cohort found higher odds of telogen effluvium with tirzepatide at every follow-up window, but reported directions rather than figures. Since tirzepatide also produces more weight loss, drug and weight effects cannot be separated.

Will my hair grow back?

That is a question for a clinician who can examine you, because diffuse shedding, patchy loss and crown thinning have different causes and different workups. Nothing here is a reason to stop a prescription on your own.

## Sources

1.  \[1\] Viquez Burboa GU, Flores Guillén MÁR, Duardo González VS (2026). GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms Skin Appendage Disorders. [PMID 42621629](https://pubmed.ncbi.nlm.nih.gov/42621629/)
2.  \[2\] Katragadda R, Hayden J, Saltagi AK, Welschmeyer AF, Quereshy HA, Karasik D (2026). Nonscarring Alopecia in Adults Treated With GLP-1s: A Propensity Score Matched TriNetX Cohort Study The Laryngoscope. [PMID 42647098](https://pubmed.ncbi.nlm.nih.gov/42647098/)
3.  \[3\] Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM (2025). Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review Cureus. [PMID 41111833](https://pubmed.ncbi.nlm.nih.gov/41111833/)

## More in Safety

-   [
    
    Medication list · Check combinations · Fluid loss · Changes kidney risk · Pharmacist · Choose a safe option
    
    ### Can You Take Ibuprofen With Ozempic? Check Kidney and Stomach Risks
    
    ](https://thisglp.com/research/can-you-take-ibuprofen-with-ozempic)
-   [
    
    1.9% · Placebo · 8.5% · Ozempic 0.5 mg · 8.8% · Ozempic 1 mg
    
    ### Does Ozempic Cause Diarrhea? Rates, Timing, and When to Call
    
    ](https://thisglp.com/research/does-ozempic-cause-diarrhea)
-   [
    
    Sit down · Prevent a fall · Check context · Glucose and fluids · Get help · Severe symptoms
    
    ### Does Ozempic Cause Dizziness? What to Check First
    
    ](https://thisglp.com/research/does-ozempic-cause-dizziness)
